Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2025

Mar 18, 2025

31996_dirs_2025-03-18_81ef60f5-ac38-4a22-aac0-0195dd380058.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2025-03-14

Reporting Person: SISITSKY NATHANIEL (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-14 Restricted Stock Units $0 A 43989 Acquired Common Stock (43989) Direct
2025-03-14 Restricted Stock Units $0 A 8798 Acquired Common Stock (8798) Direct

Footnotes

F1: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.

F2: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with annual equity award. These RSUs vest as to 1/3 (14,663 shares) on March 14, 2026, 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028.

F3: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with the Reporting Person's promotion to Chief Legal Officer. These RSUs vest as to 1/3 (2,932 shares) on March 14, 2026, 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028.